PharmaEngine Receivables

PharmaEngine (4162.TWO) currently reports a receivables of $250M as of June 2026. That compares with $200M in the prior-year period — up 24.9% year over year. Use the charts on this page to explore PharmaEngine's receivables history and peer comparisons.

PharmaEngine's receivables increased from $200M to $250M — a 24.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PharmaEngine reported $250M in receivables as of June 2026. That compares with $200M in the prior-year period — up 24.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PharmaEngine, and consider following 4162.TWO for alerts when major investors trade the stock.

PharmaEngine is classified in the Healthcare sector. On receivables, it currently shows $250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4162.TWO with unrelated industries.